- Home
- MRSN vs UG Comparison
MRSN vs UG Comparison
Compare MRSN & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- UG
- Stock Information
- Founded
- MRSN 2001
- UG 1942
- Country
- MRSN United States
- UG United States
- Employees
- MRSN N/A
- UG N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- UG Package Goods/Cosmetics
- Sector
- MRSN Health Care
- UG Consumer Discretionary
- Exchange
- MRSN Nasdaq
- UG Nasdaq
- Market Cap
- MRSN 40.7M
- UG 36.9M
- IPO Year
- MRSN 2017
- UG N/A
- Fundamental
- Price
- MRSN $0.37
- UG $8.37
- Analyst Decision
- MRSN Strong Buy
- UG
- Analyst Count
- MRSN 5
- UG 0
- Target Price
- MRSN $5.75
- UG N/A
- AVG Volume (30 Days)
- MRSN 3.1M
- UG 5.3K
- Earning Date
- MRSN 05-15-2025
- UG 05-08-2025
- Dividend Yield
- MRSN N/A
- UG 8.36%
- EPS Growth
- MRSN N/A
- UG 4.93
- EPS
- MRSN N/A
- UG 0.63
- Revenue
- MRSN $34,006,000.00
- UG $11,408,154.00
- Revenue This Year
- MRSN N/A
- UG N/A
- Revenue Next Year
- MRSN N/A
- UG N/A
- P/E Ratio
- MRSN N/A
- UG $13.21
- Revenue Growth
- MRSN N/A
- UG N/A
- 52 Week Low
- MRSN $0.26
- UG $7.73
- 52 Week High
- MRSN $2.83
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- MRSN 51.71
- UG 50.40
- Support Level
- MRSN $0.33
- UG $8.30
- Resistance Level
- MRSN $0.38
- UG $8.74
- Average True Range (ATR)
- MRSN 0.04
- UG 0.27
- MACD
- MRSN 0.00
- UG 0.03
- Stochastic Oscillator
- MRSN 58.60
- UG 45.68
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.